Vascular disrupting and antiangiogenic agents: better together than on their own
Other
OA: closed
CC0
AI-generated summary
The provided text lacks an abstract and specific details regarding the study's methodology or findings, preventing the generation of a summary that adheres to the requirement of stating what was studied and found.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (6)
- Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises via openalex
- Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia via openalex
- W2042299463 via openalex
- W2071526086 via openalex
- W2094642124 via openalex
- W4251890925 via openalex
Source provenance
- europepmc
- last seen: 2026-10-18T09:30:06.152893+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:12:29.265612+00:00
- unpaywall
- last seen: 2026-09-19T06:31:22.526400+00:00
License: CC0
· commercial use OK